SlideShare a Scribd company logo
MPO- GROUP
PRESENTATION

GROUP #10
MANISHA GARAI (PGDM-316)
GUNISHA VISHNANI (PGDM-371)
DEBANJAN BOSE (PGDM-332)
SAGAR RAUT (PGDM-301)
AWANTIKA MAURYA (PGDM-334)
G.VENU MADHAV (PGDM-336)
KIRAN NIGAD (PGDM-377)
MADHUR JAIN (PGDM-314)
SUN PHARMA
COMPANY PROFILE
Company Name Sun Pharmaceutical Industries Ltd.
Country/Territor
y
India
Business Type Pharmaceutical
Products/Service
Manufactures both Pharmaceutical and Active
Pharmaceutical Ingredients (API)
Industry Focus Therapeutic areas including
psychiatry,neorology,cardiology,diabetology,g
astroentology,respiratory and orthopaedics
Geographical
Market
World wide
Year Established 1983
Founder Dilip Shanghvi
SUN PHARMA’S GOBAL
RANKING
OBJECTIVE OF THE
PRESENTATION-
•SWOT analysis of Sun
Pharmaceutical Industries Ltd.
•Understanding of – planning
strategies, organisation
structure, control and leadership
style of the company.
•Various strategies implemented
in order to get listed in the list
of best place to work at.
SWOT ANALYSIS •Expertise in relatively
complex generic
pharmaceuticals
•Low cost generic
portfolio
•Successful acquisitions
over years
•Strong brand presence
in India and US
•Strong marketing and
sales force
Strength
SWOT ANALYSIS
Drug Price Control
order puts undue
pressure on product
prices, affecting the
profitability of the
pharmaceutical
companies.
Strick govt.
regulation & policies
afeect operational
efficiency
Office politics & too
Weakness
SWOT ANALYSIS
•Increase healthcare
awareness in urban
and rural India
•Enhance product
basket and market
presence
•Further acquisitions
will help in tapping
the emerging
global market
Opportunities
SWOT ANALYSIS •Stiff competition in generic
markets from other low cost
rivals like Cipla , Lupin,
Dr. Reddy’s Lab
•The company being more into
acquisition based growth might
lead to a stage of financial
crunch as it has already
happened in the case of Caraco
pharma where it provided debt
to Caraco and is facing
problems due to the continuous
losses made by the latter.
•Stringent patent regulations
Threats
PLANNING
STRATEGIES
Mission- Good
health and happiness
for all.
Vision- With good
health to all as a
primary objective,
Sun Pharmacy started
with an aims to be
among top 10
Generic pharmacies
and OTC player in
India with the help of
strategic growth and
stringent quality
measures.
PLANNING
STRATEGIES
ORGANISATION STRUCTURE
SUN PHARMA FOLLOWS A FUNCTIONAL UNITARY
STRUCTURE
Structured around a CEO and limited
corporate staff
Activities are grouped together by
common function
Each functional unit has different set of
duties and responsibilities
Specialisation is built into the
organisational structure
ORGANISATION STRUCTURE
Various organising teams are-
An wide range of specialists and world
class doctors
Financial audit team
Operation team
The R & D centres are supported by
around 2000 scientists and cutting edge
technologies
WHAT IS LATEST ON SUN
PHARMA?
Revenues US
4.2 billion
DETAILS OF MERGER
In April 2014 the Sun
Pharma took over Ranbaxy
The deal was set at US 4.2
billion approx.
The merger will help Sun
Pharma to enhance its
presence in emerging
pharma markets like
Russia, Brazil, South Africa
and also for better brand
building.
CONTROL MECHANISM
The company has a well
established internal control
framework
Global audit team function
carries out risk focused
audits across all
business(both India and
Global)
Operational management
team closely monitors
internal environment &
ensures that the
recommendations are
effectively implemented
Evaluation of performance
of the board, its committee
and every individual
directors are also done.
LEADERSHIP STYLE
Dilip Shanghvi , founder and
Managing Director Sun Pharma,
along with his team of CEOs,
presidents, vice-presidents and
other senior officials of the
merged entity shoulder
responsibilities to take the
company to the next level.
Sr. Officials maintain a cordial
relationship among each other
and also with their sub-ordinates
in order to reach quick decisions.
The MD engaged several world
class managers to head his
overseas venture in order to
build strong management
capabilities .
Despite suffering losses due to
overseas acquisitions , the MD
believes in not changing the top
management.
WHY SUN PHARMA IS
THE BEST PLACE TO
WORK
COMPANY’S STRATEGIES
“Attracting the right talent and
engaging them for high performance”-
focus of the company.
In order to be placed in the list of best
place to work at, the company implies
various strategies with respect to work
culture, employee benefits and HR
policies.
THE VARIOUS STRATEGIES ARE-
•Training and self development activities
to enhance and enrich employee
knowledge and skills.
•Remuneration policy for directors, key
managerial officials and other
employees.
•Aimed in providing each personnel an
environment free from discrimination
and harassment of any kind.
CONCLUSION
As Sun Pharma being a leading pharmaceutical
company , it needs to work on its drawbacks to retain
its market share in the global market.
As Sun pharma has acquisition based growth, many
a times the organisation fails to recover back its cost.
So they should have a market research team which
can give them an overall idea regarding the firms
which they plan to acquire.
Sun Pharma is a global leader in the pharmaceuticals
industry but it lack presence in the European market.
So in order to extend its reach the company can tie
up with medium scale pharmaceutical companies of
European market
 Product differentiation and innovation also play a
swot of sun pharma

More Related Content

What's hot

Project on lupin pharmaceutical(3) (1)
Project on lupin pharmaceutical(3) (1)Project on lupin pharmaceutical(3) (1)
Project on lupin pharmaceutical(3) (1)
Alkesh Parihar
 
Sun pharma ranbaxy acquisition
Sun pharma ranbaxy acquisitionSun pharma ranbaxy acquisition
Sun pharma ranbaxy acquisition
Sai Mahesh
 

What's hot (20)

Marketing Strategy of Sun Pharmaceuticals
Marketing Strategy of Sun PharmaceuticalsMarketing Strategy of Sun Pharmaceuticals
Marketing Strategy of Sun Pharmaceuticals
 
Sun Pharma Vs Lupin Pharma
Sun Pharma Vs Lupin PharmaSun Pharma Vs Lupin Pharma
Sun Pharma Vs Lupin Pharma
 
Cipla Presentation
Cipla PresentationCipla Presentation
Cipla Presentation
 
ppt
pptppt
ppt
 
Sun pharma
Sun pharmaSun pharma
Sun pharma
 
PESTLE Analysis of Sun Pharma Ltd (Business Environment Project)
PESTLE Analysis of Sun Pharma Ltd (Business Environment Project)PESTLE Analysis of Sun Pharma Ltd (Business Environment Project)
PESTLE Analysis of Sun Pharma Ltd (Business Environment Project)
 
Project on lupin pharmaceutical(3) (1)
Project on lupin pharmaceutical(3) (1)Project on lupin pharmaceutical(3) (1)
Project on lupin pharmaceutical(3) (1)
 
Sun pharma ranbaxy acquisition
Sun pharma ranbaxy acquisitionSun pharma ranbaxy acquisition
Sun pharma ranbaxy acquisition
 
“SWOT ANALYSIS OF NEW PHARMACEUTICAL COMPANY”
“SWOT ANALYSIS OF NEW PHARMACEUTICAL COMPANY”“SWOT ANALYSIS OF NEW PHARMACEUTICAL COMPANY”
“SWOT ANALYSIS OF NEW PHARMACEUTICAL COMPANY”
 
Sun pharma ppt final
Sun pharma ppt finalSun pharma ppt final
Sun pharma ppt final
 
Report on cipla
Report on ciplaReport on cipla
Report on cipla
 
Lupin
LupinLupin
Lupin
 
pharma industry ppt
pharma industry pptpharma industry ppt
pharma industry ppt
 
Indian Pharma Industry
Indian Pharma IndustryIndian Pharma Industry
Indian Pharma Industry
 
Indian pharmaceutical industry organisational structure & strategies
Indian pharmaceutical industry  organisational structure & strategiesIndian pharmaceutical industry  organisational structure & strategies
Indian pharmaceutical industry organisational structure & strategies
 
PRESENT SCENARIO OF INDIAN PHARMACEUTICAL INDUSTRY IN VIEW OF GLOBAL ...
PRESENT  SCENARIO  OF  INDIAN  PHARMACEUTICAL  INDUSTRY IN  VIEW  OF  GLOBAL ...PRESENT  SCENARIO  OF  INDIAN  PHARMACEUTICAL  INDUSTRY IN  VIEW  OF  GLOBAL ...
PRESENT SCENARIO OF INDIAN PHARMACEUTICAL INDUSTRY IN VIEW OF GLOBAL ...
 
Sun pharma financial analysis 2008-2017
Sun pharma financial analysis 2008-2017Sun pharma financial analysis 2008-2017
Sun pharma financial analysis 2008-2017
 
DR REDDYS LABS PPT
DR REDDYS LABS PPTDR REDDYS LABS PPT
DR REDDYS LABS PPT
 
Dr. Reddy's Lab - Business Model
Dr. Reddy's Lab - Business ModelDr. Reddy's Lab - Business Model
Dr. Reddy's Lab - Business Model
 
Sun Pharma Vs Lupin Pharma
Sun Pharma Vs Lupin PharmaSun Pharma Vs Lupin Pharma
Sun Pharma Vs Lupin Pharma
 

Viewers also liked

Pharmaceutical industry India
Pharmaceutical industry IndiaPharmaceutical industry India
Pharmaceutical industry India
Sushant Mishra
 
Indian Pharmaceutical Industry
Indian Pharmaceutical IndustryIndian Pharmaceutical Industry
Indian Pharmaceutical Industry
Chandni Sahgal
 
Sun pharma ranbaxy acquition
Sun pharma ranbaxy acquitionSun pharma ranbaxy acquition
Sun pharma ranbaxy acquition
Sai Mahesh
 
Ranbaxy company profile
Ranbaxy company profileRanbaxy company profile
Ranbaxy company profile
sanath_mahadi
 

Viewers also liked (15)

Sunpharma
SunpharmaSunpharma
Sunpharma
 
FULL DETAIL OF SUN PHARMA & PHARMACEUTICAL INDUSTRY 2015
FULL DETAIL OF SUN PHARMA & PHARMACEUTICAL INDUSTRY 2015FULL DETAIL OF SUN PHARMA & PHARMACEUTICAL INDUSTRY 2015
FULL DETAIL OF SUN PHARMA & PHARMACEUTICAL INDUSTRY 2015
 
Sun Pharma - Ranbaxy Merger Presentation
Sun Pharma - Ranbaxy Merger PresentationSun Pharma - Ranbaxy Merger Presentation
Sun Pharma - Ranbaxy Merger Presentation
 
Pharmaceutical Industry
Pharmaceutical IndustryPharmaceutical Industry
Pharmaceutical Industry
 
Pharmaceutical industry India
Pharmaceutical industry IndiaPharmaceutical industry India
Pharmaceutical industry India
 
Indian Pharmaceutical Industry
Indian Pharmaceutical IndustryIndian Pharmaceutical Industry
Indian Pharmaceutical Industry
 
Sun pharma ranbaxy acquition
Sun pharma ranbaxy acquitionSun pharma ranbaxy acquition
Sun pharma ranbaxy acquition
 
Sunbaxy-making of a new Indian pharma giant
Sunbaxy-making of a new Indian pharma giantSunbaxy-making of a new Indian pharma giant
Sunbaxy-making of a new Indian pharma giant
 
FDA 2013 Clinical Investigator Training Course: Biosimilar Biological Products
FDA 2013 Clinical Investigator Training Course: Biosimilar Biological ProductsFDA 2013 Clinical Investigator Training Course: Biosimilar Biological Products
FDA 2013 Clinical Investigator Training Course: Biosimilar Biological Products
 
Study On Pharmaceuticals Companies
Study On Pharmaceuticals CompaniesStudy On Pharmaceuticals Companies
Study On Pharmaceuticals Companies
 
Sun pharma Industries limited at a Glance
Sun pharma Industries limited at a GlanceSun pharma Industries limited at a Glance
Sun pharma Industries limited at a Glance
 
Ranbaxy
RanbaxyRanbaxy
Ranbaxy
 
Sunpharma present13
Sunpharma present13Sunpharma present13
Sunpharma present13
 
SunPharma Ranbaxy Acquisition
SunPharma Ranbaxy Acquisition SunPharma Ranbaxy Acquisition
SunPharma Ranbaxy Acquisition
 
Ranbaxy company profile
Ranbaxy company profileRanbaxy company profile
Ranbaxy company profile
 

Similar to swot of sun pharma

Andrew Howden Resume
Andrew Howden ResumeAndrew Howden Resume
Andrew Howden Resume
Andrew Howden
 
Glenmark pharma ppt final
Glenmark pharma ppt finalGlenmark pharma ppt final
Glenmark pharma ppt final
Suraj Warthy
 
Beximco Pharma EXODUS
Beximco Pharma EXODUSBeximco Pharma EXODUS
Beximco Pharma EXODUS
Nadim Siddik
 
MGT210 Report Beximco Pharma EXODUS
MGT210 Report Beximco Pharma EXODUSMGT210 Report Beximco Pharma EXODUS
MGT210 Report Beximco Pharma EXODUS
Nadim Siddik
 
Comprehensive Analysis on: Business Strategy of Square Pharmaceuticals Limited
Comprehensive Analysis on:  Business Strategy of Square Pharmaceuticals LimitedComprehensive Analysis on:  Business Strategy of Square Pharmaceuticals Limited
Comprehensive Analysis on: Business Strategy of Square Pharmaceuticals Limited
Sadman Prodhan
 
united phosphorous limited
united phosphorous limitedunited phosphorous limited
united phosphorous limited
Siva Bharath
 

Similar to swot of sun pharma (20)

Andrew Howden Resume
Andrew Howden ResumeAndrew Howden Resume
Andrew Howden Resume
 
Glenmark pharma ppt final
Glenmark pharma ppt finalGlenmark pharma ppt final
Glenmark pharma ppt final
 
Glenmark pharma ppt final
Glenmark pharma ppt finalGlenmark pharma ppt final
Glenmark pharma ppt final
 
Director of Sales - Consumer Heath Care - Strides Shasun INC. USA
Director of Sales - Consumer Heath Care - Strides Shasun INC. USADirector of Sales - Consumer Heath Care - Strides Shasun INC. USA
Director of Sales - Consumer Heath Care - Strides Shasun INC. USA
 
Beximco Pharma EXODUS
Beximco Pharma EXODUSBeximco Pharma EXODUS
Beximco Pharma EXODUS
 
Sun pharma incentive policy
Sun pharma incentive policySun pharma incentive policy
Sun pharma incentive policy
 
Glaxo smith kline
Glaxo smith klineGlaxo smith kline
Glaxo smith kline
 
Beximco pharma
Beximco pharmaBeximco pharma
Beximco pharma
 
Human resource management in pharma sector
Human resource management in pharma sectorHuman resource management in pharma sector
Human resource management in pharma sector
 
Resume deepak
Resume deepakResume deepak
Resume deepak
 
Glenmark Sales & Distribution Management
Glenmark Sales & Distribution ManagementGlenmark Sales & Distribution Management
Glenmark Sales & Distribution Management
 
Assignment on HRM activities of square pharma. ltd.
Assignment on HRM activities of square pharma. ltd.Assignment on HRM activities of square pharma. ltd.
Assignment on HRM activities of square pharma. ltd.
 
MGT210 Report Beximco Pharma EXODUS
MGT210 Report Beximco Pharma EXODUSMGT210 Report Beximco Pharma EXODUS
MGT210 Report Beximco Pharma EXODUS
 
Strategic management - An Outlook on Growth strategy
Strategic management - An Outlook on Growth strategyStrategic management - An Outlook on Growth strategy
Strategic management - An Outlook on Growth strategy
 
new mba project
new mba projectnew mba project
new mba project
 
Assignment
AssignmentAssignment
Assignment
 
Comprehensive Analysis on: Business Strategy of Square Pharmaceuticals Limited
Comprehensive Analysis on:  Business Strategy of Square Pharmaceuticals LimitedComprehensive Analysis on:  Business Strategy of Square Pharmaceuticals Limited
Comprehensive Analysis on: Business Strategy of Square Pharmaceuticals Limited
 
Training and Develpoment
 Training and Develpoment Training and Develpoment
Training and Develpoment
 
united phosphorous limited
united phosphorous limitedunited phosphorous limited
united phosphorous limited
 
Industrial training report
Industrial training report Industrial training report
Industrial training report
 

More from Debanjan Bose (12)

A trend analysis of market cap for investment decision
A trend analysis of market cap for investment decisionA trend analysis of market cap for investment decision
A trend analysis of market cap for investment decision
 
Sony Restructuring
Sony RestructuringSony Restructuring
Sony Restructuring
 
Forex infosys
Forex  infosysForex  infosys
Forex infosys
 
Equity Research of Indian IT sector
Equity Research of Indian IT sectorEquity Research of Indian IT sector
Equity Research of Indian IT sector
 
Change Management
Change ManagementChange Management
Change Management
 
Larsen and Toubro
Larsen and ToubroLarsen and Toubro
Larsen and Toubro
 
Analysis of HPCL
Analysis of HPCLAnalysis of HPCL
Analysis of HPCL
 
Eco commodity wise import and export
Eco commodity wise import and exportEco commodity wise import and export
Eco commodity wise import and export
 
News analysis
News analysisNews analysis
News analysis
 
Sir alex ferguson
Sir alex fergusonSir alex ferguson
Sir alex ferguson
 
Sir alex ferguson
Sir alex fergusonSir alex ferguson
Sir alex ferguson
 
Online to offline
Online to offlineOnline to offline
Online to offline
 

Recently uploaded

Recently uploaded (9)

Travis Hills of Minnesota Leads Livestock Water and Energy in Sustainable Inn...
Travis Hills of Minnesota Leads Livestock Water and Energy in Sustainable Inn...Travis Hills of Minnesota Leads Livestock Water and Energy in Sustainable Inn...
Travis Hills of Minnesota Leads Livestock Water and Energy in Sustainable Inn...
 
Create the recognition your teams deserve.pptx
Create the recognition your teams deserve.pptxCreate the recognition your teams deserve.pptx
Create the recognition your teams deserve.pptx
 
Risk Management in Banks - Overview (May 2024)
Risk Management in Banks - Overview (May 2024)Risk Management in Banks - Overview (May 2024)
Risk Management in Banks - Overview (May 2024)
 
Oprah Winfrey: A Leader in Media, Philanthropy, and Empowerment | CIO Women M...
Oprah Winfrey: A Leader in Media, Philanthropy, and Empowerment | CIO Women M...Oprah Winfrey: A Leader in Media, Philanthropy, and Empowerment | CIO Women M...
Oprah Winfrey: A Leader in Media, Philanthropy, and Empowerment | CIO Women M...
 
ANIn Delhi Feb 2022 | Design the Future with Technology Disruption by N Kisho...
ANIn Delhi Feb 2022 | Design the Future with Technology Disruption by N Kisho...ANIn Delhi Feb 2022 | Design the Future with Technology Disruption by N Kisho...
ANIn Delhi Feb 2022 | Design the Future with Technology Disruption by N Kisho...
 
Project Management Professional (PMP)® from PMI
Project Management Professional (PMP)® from PMIProject Management Professional (PMP)® from PMI
Project Management Professional (PMP)® from PMI
 
TCS AI for Business Study – Key Findings
TCS AI for Business Study – Key FindingsTCS AI for Business Study – Key Findings
TCS AI for Business Study – Key Findings
 
Flexi time, Flexi work, QWL and Role Effectiveness
Flexi time, Flexi  work, QWL and  Role EffectivenessFlexi time, Flexi  work, QWL and  Role Effectiveness
Flexi time, Flexi work, QWL and Role Effectiveness
 
Founder-Game Director Workshop (Session 1)
Founder-Game Director  Workshop (Session 1)Founder-Game Director  Workshop (Session 1)
Founder-Game Director Workshop (Session 1)
 

swot of sun pharma

  • 1. MPO- GROUP PRESENTATION  GROUP #10 MANISHA GARAI (PGDM-316) GUNISHA VISHNANI (PGDM-371) DEBANJAN BOSE (PGDM-332) SAGAR RAUT (PGDM-301) AWANTIKA MAURYA (PGDM-334) G.VENU MADHAV (PGDM-336) KIRAN NIGAD (PGDM-377) MADHUR JAIN (PGDM-314)
  • 3.
  • 4. COMPANY PROFILE Company Name Sun Pharmaceutical Industries Ltd. Country/Territor y India Business Type Pharmaceutical Products/Service Manufactures both Pharmaceutical and Active Pharmaceutical Ingredients (API) Industry Focus Therapeutic areas including psychiatry,neorology,cardiology,diabetology,g astroentology,respiratory and orthopaedics Geographical Market World wide Year Established 1983 Founder Dilip Shanghvi
  • 6. OBJECTIVE OF THE PRESENTATION- •SWOT analysis of Sun Pharmaceutical Industries Ltd. •Understanding of – planning strategies, organisation structure, control and leadership style of the company. •Various strategies implemented in order to get listed in the list of best place to work at.
  • 7.
  • 8. SWOT ANALYSIS •Expertise in relatively complex generic pharmaceuticals •Low cost generic portfolio •Successful acquisitions over years •Strong brand presence in India and US •Strong marketing and sales force Strength
  • 9. SWOT ANALYSIS Drug Price Control order puts undue pressure on product prices, affecting the profitability of the pharmaceutical companies. Strick govt. regulation & policies afeect operational efficiency Office politics & too Weakness
  • 10. SWOT ANALYSIS •Increase healthcare awareness in urban and rural India •Enhance product basket and market presence •Further acquisitions will help in tapping the emerging global market Opportunities
  • 11. SWOT ANALYSIS •Stiff competition in generic markets from other low cost rivals like Cipla , Lupin, Dr. Reddy’s Lab •The company being more into acquisition based growth might lead to a stage of financial crunch as it has already happened in the case of Caraco pharma where it provided debt to Caraco and is facing problems due to the continuous losses made by the latter. •Stringent patent regulations Threats
  • 12. PLANNING STRATEGIES Mission- Good health and happiness for all. Vision- With good health to all as a primary objective, Sun Pharmacy started with an aims to be among top 10 Generic pharmacies and OTC player in India with the help of strategic growth and stringent quality measures.
  • 14. ORGANISATION STRUCTURE SUN PHARMA FOLLOWS A FUNCTIONAL UNITARY STRUCTURE Structured around a CEO and limited corporate staff Activities are grouped together by common function Each functional unit has different set of duties and responsibilities Specialisation is built into the organisational structure
  • 15. ORGANISATION STRUCTURE Various organising teams are- An wide range of specialists and world class doctors Financial audit team Operation team The R & D centres are supported by around 2000 scientists and cutting edge technologies
  • 16. WHAT IS LATEST ON SUN PHARMA?
  • 18. DETAILS OF MERGER In April 2014 the Sun Pharma took over Ranbaxy The deal was set at US 4.2 billion approx. The merger will help Sun Pharma to enhance its presence in emerging pharma markets like Russia, Brazil, South Africa and also for better brand building.
  • 19. CONTROL MECHANISM The company has a well established internal control framework Global audit team function carries out risk focused audits across all business(both India and Global) Operational management team closely monitors internal environment & ensures that the recommendations are effectively implemented Evaluation of performance of the board, its committee and every individual directors are also done.
  • 20. LEADERSHIP STYLE Dilip Shanghvi , founder and Managing Director Sun Pharma, along with his team of CEOs, presidents, vice-presidents and other senior officials of the merged entity shoulder responsibilities to take the company to the next level. Sr. Officials maintain a cordial relationship among each other and also with their sub-ordinates in order to reach quick decisions. The MD engaged several world class managers to head his overseas venture in order to build strong management capabilities . Despite suffering losses due to overseas acquisitions , the MD believes in not changing the top management.
  • 21. WHY SUN PHARMA IS THE BEST PLACE TO WORK
  • 22. COMPANY’S STRATEGIES “Attracting the right talent and engaging them for high performance”- focus of the company. In order to be placed in the list of best place to work at, the company implies various strategies with respect to work culture, employee benefits and HR policies.
  • 23. THE VARIOUS STRATEGIES ARE- •Training and self development activities to enhance and enrich employee knowledge and skills. •Remuneration policy for directors, key managerial officials and other employees. •Aimed in providing each personnel an environment free from discrimination and harassment of any kind.
  • 24. CONCLUSION As Sun Pharma being a leading pharmaceutical company , it needs to work on its drawbacks to retain its market share in the global market. As Sun pharma has acquisition based growth, many a times the organisation fails to recover back its cost. So they should have a market research team which can give them an overall idea regarding the firms which they plan to acquire. Sun Pharma is a global leader in the pharmaceuticals industry but it lack presence in the European market. So in order to extend its reach the company can tie up with medium scale pharmaceutical companies of European market  Product differentiation and innovation also play a